Clinical Trial Update: Influence of OATP1B1 and BRCP Genotype on Rosuvastatin PK, PD and Lipidomics in Hyperlipidemic Patients [Phase 4]

View source ↗

Summary

Phase 4 study assessing how OATP1B1 and BRCP genotypes influence rosuvastatin pharmacokinetics, pharmacodynamics, and lipidomics in hypercholesterolemia; the tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hypercholesterolemia | Phase 4 | Status: COMPLETED